Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Anteris Technologies Global Corp.

News headline image
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Announces Results for the Third Quarter of 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Announces Results for the Second Quarter of 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR LMAT
News headline image
Anteris Announces Results for the First Quarter of 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Reports One-Year Patient Outcomes for DurAVR® THV
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Reports 2024 Financial Results and Provides Corporate Update
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering
From Anteris Technologies Global Corp.
Via Business Wire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering
From Anteris Technologies Global Corp.
Via Business Wire
Tickers ASX:AVR
News headline image
Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering
From Anteris Technologies Global Corp.
Via Business Wire
Tickers ASX:AVR
News headline image
Anteris Technologies Global Corp. Files Registration Statement for Proposed US Initial Public Offering
From Anteris Technologies Global Corp.
Via Business Wire
Tickers ASX:AVR
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.